Please login to the form below
Jan-Uwe Claas to head up Grunenthal UK
Chris Matijasevic will retire and Jan-Uwe Claas take over at Grünenthal UK
German pharma company Grünenthal has appointed Jan-Uwe Claas to head up its UK subsidiary.
Claas joins Grünenthal UK from the company's head office in Aachen, Germany, where he served as senior VP marketing Europe and Australia.
Prior to spending almost 10 years with Grünenthal Claas worked with J&J Pharmaceuticals for more than five years in different commercial functions.
He takes over as general manager of Grünenthal UK and Ireland from Chris Matijasevic who is retiring after years at Grünenthal. Earlier in his career he spent 14 years at Janssen and 10 years at Boots.
Share
Related Hub content
COVID-19 Updates and Daily News
Featured jobs
-
Senior Health Psychologist, London
-
Highly competitive salary
-
Head of Health Psychology, London
-
Highly competitive salary
- Senior Account Executive, Medical/ Brand Communications, London
-
Highly competitive salary
-
Consultant Dermatologist (Freelance)
-
£110-180ph
- Senior Analyst, Market Access, UK, Home based
-
Highly competitive salary
- Boehringer Ingelheim’s pulmonary fibrosis treatment produces promising phase 2 data
- Scientists discover new approach to treat brain tumours
- Almirall and Inserm Transfert to develop innovative vitiligo treatments
- EIT Health and Biogen announce winners of first ‘neurotechprize’
- Roche collaborates with Global Fund to strengthen critical diagnostics infrastructure
- Assessing the value of interim analyses in clinical trials
- Why testing shouldn't be confined to the lab
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Live Webinar: Engaging Patients "Just-In-Time" with Machine Learning
- Almirall and Inserm Transfert to develop innovative vitiligo treatments
- Recognising HIV Vaccine Awareness Day
- AstraZeneca and UK-based biotech company RQ BIO sign licencing agreement
- How scientific storytelling can help Pharma cut through the noise
- How patient experience mapping can improve patient recruitment
- Christian Schade joins Aprea AB
- Getting patients to engage with clinical trials
- Roche collaborates with Global Fund to strengthen critical diagnostics infrastructure
- Mapping patient pathways – with a focus on patient-centricity
PMHub
Nucleus Global
Nucleus Global is the largest specialist medical communications network in the world. Globally, we have over 800 experts delivering world-class...
Latest intelligence
- Leveraging Real-World Evidence for Cell and Gene Therapies
- Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...
- Food Allergy – Is avoidance the only option?
- Following on from Allergy Awareness Week 2022, we’re continuing the discussion about food allergies and the experiences of those who live with them. In this blog, we discuss the current...
- Serious about sustainability?
- Get to know our new Sustainability Officer here at Cuttsy+Cuttsy...
